Skip to main content
Edwards Lifesciences Logo
Edwards Lifesciences Logo

KONECT RESILIA aortic valved conduit

Konect resilia
KONECT RESILIA

First pre-assembled, ready-to-implant‡ valved conduit with RESILIA tissue.

The ready-to-implant‡ KONECT RESILIA aortic valved conduit helps patients maintain their active lifestyles and reduces the complexity of bio-Bentall procedures.*

RESILIA Tissue

Edwards Lifesciences' integrity preservation technology transforms bovine pericardial tissue into RESILIA tissue, effectively eliminating free aldehydes, while protecting and preserving the tissue.

RESILIA tissue is the first to deliver the combination of:

resilia tissue features

A Proven Heritage

KONECT RESILIA aortic valved conduit is built on the proven performance of both the Carpentier–Edwards PERIMOUNT valve platform and the Valsalva graft.

valve platform

Valve platform

Proven performance of the PERIMOUNT valve design – a design with durability data spanning 30 years

gelweave valsalva graft

Valsalva graft

The world’s first anatomically designed aortic root graft with over 15 years of aortic root surgery clinical experience2,3

Ready to Implant‡

The pre-assembled KONECT RESILIA aortic valved conduit intuitively eliminates procedural steps§, which is especially important in emergency cases.

ready to implant 1

Edwards’ quality-controlled pre-assembly of valve and Valsalva graft provides a consistent and reliable hemostatic connection

ready to implant 2

Pre-mounted to an easy-access, single-cut release holder

* By eliminating procedure steps.
† RESILIA tissue tested against commercially available bovine pericardial tissue from Edwards in a juvenile sheep model.1
‡ Consult instructions for use for device preparation instructions.
§ As compared to self-assembled tissue valved conduits.

Experience the RESILIA tissue portfolio difference

Learn more
RESILIA Tout CTA

Valsalva graft

1 / 3
gelweave valsalva graft
‌
‌
gelweave valsalva graft
video thumbnail
video thumbnail

Valsalva graft

Edwards KONECT RESILIA aortic valved conduit procedure animation

Edwards KONECT RESILIA aortic valved conduit animation

Download brochure

Specifications

Intended use and indications for use

The KONECT RESILIA AVC, Model 11060A, is intended for use as a replacement for the aortic heart valve and the ascending aorta.

The KONECT RESILIA AVC, Model 11060A, is indicated for patients who require replacement of their native or prosthetic aortic valve, and the associated repair or replacement of a damaged or diseased ascending aorta.

The KONECT RESILIA AVC, Model 11060A, should only be used with the dedicated sizers that replicate the DualFit sewing ring (Model 1190 Sizers and Tray).

Materials list

  • Valve leaflets: Bovine pericardium
  • Stent: Cobalt-chromium alloy, polyester
  • Fabric covering stent: Polyester cloth
  • Valve sewing ring: Silicone rubber
  • Woven polyester impregnated with gelatin

Tissue platform

  • Model 11060A features RESILIA tissue, bovine pericardial tissue transformed by a novel integrity preservation technology, which incorporates two proprietary features that effectively eliminate free aldehydes while protecting and preserving the tissue

General product information

  • Storage temperature: 10°C to 25°C
  • Storage: Dry storage
  • Rinse procedure: Immerse device in sterile saline for 5 minutes

Thank you for your interest in Edwards Lifesciences

Sign up now and don't miss any updates about our surgical therapies.

If you would like further information about our privacy policy, please click here.

Would you like to opt-in to receive future email communications from 
Edwards Lifesciences?

This includes notification of future symposia, forums, conference activities, product updates, and educational events.

Clinical data on valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up of up to 10 years in process.4

References

  1. Flameng W, Hermans H, Verbeken E, et al. A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model. J Thorac Cardiovasc Surg. 2015;149(1):340-345.
  2. De Paulis R, De Matteis GM, Nardi P, et al. A new aortic Dacron conduit for surgical treatment of aortic root pathology. Ital Heart J. 2000 Jul;1(7):457-63.
  3. De Paulis R, Chirichilli I, Scaffa R, et al. Long-term results of the valve reimplantation technique using a graft with sinuses. J Thorac Cardiovasc Surg. 2016 Jan;151(1):112-9.
  4. Beaver T, Bavaria JE, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024 Sep;168(3):781-791.
Medical device for professional use

Medical device for professional use

For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).